hybrid
hybridoma
quadroma
deriv
fuse
least
two
hybridoma
produc
differ
antibodi
predefin
specif
result
cell
secret
immunoglobulin
parent
also
hybrid
molecul
manifest
bind
characterist
individu
fusion
partner
purif
desir
bispecif
immunoprob
high
specif
activ
mixtur
bispecif
monospecif
monoclon
antibodi
requir
special
strategi
use
dual
sequenti
affin
chromatographi
prote
chromatographi
follow
maminophenyleboron
acid
agaros
column
purifi
bispecif
monoclon
antibodi
bsmab
preform
hrpo
horseradish
peroxidas
complex
bsmabhrpo
quadroma
cultur
supernat
initi
process
prote
column
isol
speci
immunoglobulin
preenrich
fraction
subsequ
pass
aminophenyleboron
acid
column
super
satur
hrpo
column
matrix
abil
bind
protein
hrpo
vicin
diol
enzym
load
column
captur
desir
bispecif
antisarscov
antihrpo
speci
elimin
monospecif
antisarscov
mab
result
high
specif
activ
diagnost
probe
presenc
antihrpo
mab
accept
impur
bind
target
sarscov
np
antigen
get
wash
elisa
procedur
crown
bispecif
monoclon
antibodi
bsmab
uniqu
macromolecul
function
crosslink
two
differ
predetermin
bind
specif
antibodi
uniqu
applic
immunodiagnost
immunotherapi
sinc
report
develop
bifunct
antibodi
hybrid
hybridoma
increas
attent
focus
crosslink
immunoprob
incorpor
two
differ
paratop
singl
antibodi
molecul
laboratori
extens
adopt
hybrid
hybridoma
method
gener
differ
bsmab
diagnost
applic
antibodi
enzym
tag
use
extens
biochem
immunochem
applic
literatur
previou
work
laboratori
result
develop
sever
bsmab
antitumor
antigen
specif
one
arm
antienzym
specif
arm
laboratori
previous
purifi
alkalin
phosphataselabel
bsmab
use
mimet
red
matrix
purif
uncomplex
bsmab
hrpoagaros
column
challeng
obtain
bispecif
immunoprob
high
specif
activ
puriti
circumv
use
benzhydroxam
acid
agaros
purifi
antibodi
tag
hrpo
preform
immun
complex
benzhydroxam
acid
agaros
bhaagaros
report
bind
activ
site
hrpo
unfortun
due
discontinu
bhaagaros
product
vendor
attempt
develop
altern
affin
chromatographi
method
purif
bsmab
one
arm
specif
hrpo
arm
specif
sever
acut
respiratori
syndrom
sarscov
nucleoprotein
np
antigen
use
novel
boron
affin
matrix
call
maminophenylboron
acid
agaros
apbaagaros
immobil
phenylboron
acid
util
select
retain
carbohydr
catecholamin
prostaglandin
ribonucleosid
steroid
boron
acid
form
revers
bond
gener
five
six
member
cyclic
complex
mild
condit
immobil
boron
acid
deriv
report
form
revers
complex
diolcontain
compound
nucleotid
nucleosid
nucleic
acid
carbohydr
use
immobil
phenylboron
acid
deriv
separ
diolcontain
nucleotid
first
suggest
nearli
four
decad
ago
abil
boron
form
specif
complex
cisdiol
also
explor
separ
glycoprotein
util
carbohydr
moieti
bind
site
advantag
sinc
region
gener
involv
biolog
activ
therefor
mani
glycoprotein
includ
hormon
antibodi
enzym
horseradish
peroxidas
lactamas
hexokinas
dehydrogenas
retain
biolog
activ
even
carbohydr
region
modifi
alter
specul
apbaagaros
presatur
hrpo
could
purifi
bsmab
hrpolabel
bsmab
complex
advantag
bsmab
monospecif
mab
two
non
ident
paratop
incorpor
singl
antibodi
effici
cross
link
avoid
chemic
conjug
reduc
assay
format
one
step
turn
reduc
time
assay
low
signal
nois
ratio
due
molecular
uniform
bsmab
bispecif
design
gener
theoret
limit
tracer
specif
activ
everi
molecul
bound
hrpo
quadroma
gener
abund
bsmab
thu
provid
detect
antibodi
total
absenc
random
crosslink
enzym
describ
altern
method
purif
hrpolabel
bsmab
applic
immunoassay
horseradish
peroxidas
type
vi
maminophenylboron
acid
agaros
bind
capac
hrpo
mgml
gel
prote
sepharos
goat
antimous
igg
hrpo
conjug
antibodi
obtain
sigma
st
loui
mo
usa
dialysi
tube
mw
cut
obtain
biodesign
inc
carmel
ny
usa
elisa
plate
nunc
tmb
tetramethylbenzidin
substrat
obtain
kpl
scientif
rat
hybridoma
secret
monospecif
antihorseradish
peroxidas
antibodi
obtain
late
dr
c
milstein
mrc
laboratori
molecular
biolog
cambridg
uk
sarscov
nucleocapsid
protein
np
hybridoma
secret
antinp
monoclon
antibodi
class
develop
laboratori
manuscript
prepar
well
character
bsmab
secret
quadroma
develop
laboratori
bind
hrpo
nucleocapsid
protein
sarscov
one
molecul
manuscript
prepar
elisa
detect
bispecif
antibodiess
bsmab
hrpolabel
bsmab
plate
coat
l
sarscov
np
antigen
gml
incub
overnight
h
c
plate
wash
three
time
pb
contain
tween
pbst
incub
bsapb
h
c
block
nonspecif
bind
site
plate
wash
l
variou
dilut
bsmab
crude
cultur
supernat
prote
purifi
fraction
cultur
supernat
ad
well
incub
h
c
plate
wash
l
gml
hrpo
bsapb
ad
h
c
hrpolabel
bsmab
assess
step
addit
hrpo
elimin
fig
color
develop
use
tetramethylbenzidin
tmb
substrat
initi
experi
crude
hrpo
type
vi
sigma
inc
usa
dissolv
mm
potassium
phosphat
kh
po
k
hpo
ph
buffer
final
concentr
mgml
ml
load
column
contain
ml
preequilibr
apbaagaros
matrix
column
flow
rate
mlh
column
wash
column
volum
potassium
phosphat
buffer
ph
elut
phosphat
buffer
contain
sorbitol
unbound
elut
fraction
ml
size
collect
analyz
purif
bsmab
complex
hrpo
perform
two
step
use
combin
affin
chromatographi
first
step
immunoglobulin
parent
monospecif
bispecif
monoclon
antibodi
purifi
supernat
prote
purif
immunoglobulin
pass
hrpo
satur
mg
hrpoml
gel
maminophenylboron
acid
agaros
column
eluat
expect
enrich
bsmab
monospecif
antihrpo
antibodi
complex
hrpo
detail
procedur
given
supernat
l
quadroma
cultur
centrifug
c
rpm
min
remov
cell
crude
immunoglobulin
supernat
load
ml
bed
volum
prote
sepharos
column
equilibr
phosphat
buffer
salin
pb
ph
column
wash
absorb
nm
wash
reach
zero
bound
immunoglobulin
elut
glycin
ph
fraction
neutral
tri
ph
elut
fraction
read
nm
fraction
constitut
peak
pool
dialyz
pb
test
bsmab
activ
elisa
pool
eluat
would
contain
mixtur
antinp
antihrpo
mab
bsmab
capabl
bind
np
hrpo
antigen
follow
procedur
allow
antihrpo
bsmab
bind
hrpo
alreadi
bound
apbaagaros
column
get
elut
abil
apbaagaros
bind
carbohydr
moieti
hrpo
exploit
purif
bsmab
apbaagaros
wash
three
time
potassium
phosphat
buffer
ph
glycoprotein
bind
site
apbaagaros
satur
mg
hrpo
per
ml
bed
volum
hrpo
mix
ml
apbaagaros
incub
c
overnight
continu
gentl
mix
mixtur
wash
potassium
phosphat
buffer
ph
remov
unbound
hrpo
ml
size
column
pack
hrpo
satur
apbaagaros
hrpoapbaagaros
matrix
equilibr
potassium
phosphat
buffer
mixtur
mab
bsmab
obtain
prote
purif
load
hrpoapbaagaros
matrix
column
flow
rate
mlh
unbound
eluat
expect
contain
monospecif
antisarscov
antibodi
load
column
wash
column
volum
potassium
phosphat
buffer
elut
potassium
phosphat
buffer
contain
sorbitol
unbound
elut
fraction
ml
size
collect
separ
analyz
bsmab
activ
posit
fraction
pool
dialyz
phosphat
buffer
protein
estim
biorad
protein
assay
initi
hrpo
purifi
alon
order
test
apbaagaros
column
establish
affin
purif
method
peroxidas
describ
previous
ml
column
pack
ml
gel
column
first
wash
potassium
phosphat
buffer
ph
equilibr
buffer
approxim
mg
peroxidas
dissolv
equilibr
buffer
load
apbaagaros
column
column
wash
subsequ
absorb
return
baselin
elut
accomplish
use
sorbitol
equilibr
buffer
absorb
collect
fraction
record
fraction
test
elisa
plate
coat
antihrpo
antibodi
order
assay
activ
peroxidas
fraction
protein
absorb
seen
unbound
elut
fraction
hrpo
activ
much
higher
elut
fraction
compar
unbound
fraction
fig
unbound
elut
fraction
bsmab
subject
elisa
activ
bsmab
activ
np
antigen
coat
plate
chromatograph
profil
prote
puri
fig
direct
elisa
format
bsmab
activ
format
use
detect
presenc
hrpolabel
bsmab
apbaagaros
column
plate
coat
sarscov
np
antigen
l
gml
overnight
h
c
incub
bsapb
h
c
block
nonspecif
bind
site
l
aliquot
variou
dilut
bsmab
crude
cultur
supernat
prote
purifi
fraction
cultur
supernat
ad
well
incub
h
c
plate
wash
pb
l
gml
hrpo
bsapb
ad
h
c
hrpolabel
bsmab
assess
step
addit
hrpo
elimin
color
develop
use
tmb
substrat
fie
shown
fig
observ
larg
amount
protein
bind
unbound
column
show
neglig
peroxidas
activ
higher
protein
amount
compar
elut
fraction
show
small
amount
protein
high
peroxidas
activ
fraction
subject
elisa
detect
hrpolabel
bsmab
elut
fraction
high
peroxidas
activ
pool
dialyz
pb
yield
purifi
total
igg
mg
estim
biorad
assay
prote
purifi
antibodi
mg
mixtur
parent
monospecif
antihrpo
antisarscov
fig
purif
profil
bsmab
cultur
supernat
prote
column
bsmab
activ
correspond
fraction
one
liter
quadroma
supernat
process
ml
prote
column
elut
glycin
buffer
ph
obtain
total
immunoglobulin
fraction
test
protein
bsmab
activ
bispecif
antisarscov
antihrpo
antibodi
load
hrpo
satur
apbaagaros
column
purif
profil
reveal
presenc
protein
unbound
elut
fraction
analysi
fraction
unbound
elut
elisa
hrpo
bound
antibodi
reveal
littl
hrpo
activ
unbound
fraction
howev
high
hrpo
activ
seen
elut
fraction
fig
absorb
peak
correspond
singl
peak
peroxidas
activ
elut
fraction
final
yield
purifi
bispecif
antibodyhrpo
complex
mg
elisa
valu
show
copurif
bsmabhrpo
complex
elut
fraction
constitut
second
peak
sdspage
analysi
perform
observ
natur
variou
fraction
gel
stain
coomassi
blue
observ
protein
sampl
includ
crude
mix
antibodi
prote
purifi
apbaagaros
purifi
antibodi
analyz
sdspage
heavi
kda
mw
two
light
chain
band
kda
mw
characterist
bispecif
speci
observ
data
omit
summari
flow
chart
yield
antibodi
step
shown
fig
monoclon
antibodi
mab
repres
one
fastest
grow
area
new
diagnost
drug
develop
within
pharmaceut
industri
number
applic
use
mab
involv
chemic
manipul
antibodi
cre
ate
coval
immunoconjug
enzym
drug
etc
refin
chemic
conjug
method
employ
heterobifunct
crosslink
mitig
problem
random
conjug
entir
elimin
bsmab
intrins
bind
site
two
antigen
capabl
form
uniform
homogen
reproduc
high
specif
activ
immunoconjug
one
two
entiti
predetermin
order
crosslink
abil
bsmab
two
defin
antigen
make
better
altern
wide
use
chemic
coval
crosslink
method
least
major
area
appli
immunolog
immunoassay
immunohistochemistri
immunotarget
wide
rang
potenti
applic
employ
probe
describ
literatur
one
major
limit
use
bsmab
produc
hybrid
hybridoma
product
parent
monospecif
antibodi
along
bsmab
henc
purif
bsmab
essenti
laboratori
exploit
properti
benzhydroxam
acid
agaros
bha
bind
peroxidas
purifi
bsmab
coval
noncoval
bound
hrpo
due
commerci
nonavail
bha
upfront
chromatographi
copenhagan
denmark
attempt
develop
altern
affin
chromatographi
method
purif
bsmab
one
arm
specif
hrpo
arm
specif
sarscov
nucleoprotein
antigen
use
novel
boron
affin
gel
avail
maminophenylboron
acid
agaros
bind
hrpo
abpa
purif
bsmab
inevit
yield
antibodi
bound
hrpo
higher
specif
activ
emphas
purifi
bsmab
either
bha
apba
free
hrpo
monospecif
antihrpo
also
get
copurifi
howev
presenc
monospecif
antihrpo
antibodi
complex
hrpo
issu
abl
bind
target
np
antigen
coat
plate
thu
wash
elisa
elut
condit
affin
chromatographi
mild
potassium
phosphat
buffer
contain
sorbitol
use
routin
use
biolog
applic
procedur
adopt
affin
purif
protein
attach
peroxidas
chemic
conjug
antibodi
purifi
hrpoantihrpo
bispecif
antibodi
immun
complex
could
directli
use
vitro
diag
nostic
immunohistolog
wherein
second
arm
bispecif
antibodi
bind
specif
target
sarscov
antigen
tumor
marker
common
purif
method
bsmab
combin
proteina
ionexchang
chromatographi
size
exclus
chromatograph
techniqu
use
purifi
bsmab
mixtur
mono
bispecif
speci
nonspecif
method
subject
trial
error
time
consum
use
benzhydroxam
acid
agaros
ideal
method
quickli
easili
purifi
bsmab
label
hrpo
develop
novel
dual
sequenti
affin
procedur
maminophenylboron
acid
agaros
conveni
altern
method
purif
bsmab
protein
conjug
peroxidas
use
l
bsmab
cultur
supernat
abl
obtain
mg
high
specif
activ
hrpobsmab
complex
along
hrpoantihrpo
antibodi
complex
fig
enough
elisa
plate
well
